Pipeline Watch: ASCO Reveals Clinical Progress With Anticancers

Top-Line Results With Ozanimod, Remdesivir, Sulopenem

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.